HARROW HEALTH, INC. Uncategorized Contracts & Agreements
54 Contracts & Agreements
- Description of the Companys Securities (Filed With SEC on March 19, 2024)
- Description of the Companys Securities (Filed With SEC on March 23, 2023)
- Expansion Term Letter Agreement between Eyepoint Pharmaceuticals, Inc. and ImprimisRx, LLC dated December 6, 2021 (Filed With SEC on March 10, 2022)
- Description of the Companys Securities (Filed With SEC on March 10, 2022)
- First Amendment to Commercial Alliance Agreement between Eyepoint Pharmaceuticals, Inc. and ImprimisRx, LLC dated November 13, 2020 (Filed With SEC on March 8, 2021)
- Description of the Companys Securities (Filed With SEC on March 8, 2021)
- Commercial Alliance Agreement between Eyepoint Pharmaceuticals, Inc. and ImprimisRx, LLC dated August 1, 2020 (Filed With SEC on November 9, 2020)
- Description of the Companys Securities (Filed With SEC on March 13, 2020)
- Eton Letter dated September 20, 2017 (Filed With SEC on September 21, 2017)
- ConsultingAgreement (Filed With SEC on August 10, 2017)
- ConsultingAgreement (Filed With SEC on August 10, 2017)
- ConsultingAgreement (Filed With SEC on August 10, 2017)
- ConsultingAgreement (Filed With SEC on August 10, 2017)
- ASSETPURCHASE AGREEMENT (Filed With SEC on August 10, 2017)
- AMENDEDAND RESTATED CERTIFICATEOF INCORPORATION OF ETONPHARMACEUTICALS, INC. ADelaware Corporation (Pursuantto Sections 242 and 245 of the GeneralCorporation Law of the State of... (Filed With SEC on June 20, 2017)
- LICENSEAGREEMENT (Filed With SEC on April 6, 2017)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on March 22, 2017)
- STOCKPURCHASE AGREEMENT (Filed With SEC on February 17, 2017)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on December 23, 2016)
- [REMAINDEROF PAGE LEFT INTENTIONALLY BLANK] (Filed With SEC on April 26, 2016)
- IMPRIMISPHARMACEUTICALS, INC. EMPLOYMENTAGREEMENT (Filed With SEC on April 26, 2016)
- [REMAINDEROF PAGE LEFT INTENTIONALLY BLANK] (Filed With SEC on April 26, 2016)
- IMPRIMISPHARMACEUTICALS, INC. EMPLOYMENTAGREEMENT (Filed With SEC on April 26, 2016)
- [REMAINDEROF PAGE LEFT INTENTIONALLY BLANK] (Filed With SEC on April 26, 2016)
- IMPRIMISPHARMACEUTICALS, INC. EMPLOYMENTAGREEMENT (Filed With SEC on April 26, 2016)
- COMMISSIONAGREEMENT (Filed With SEC on March 23, 2016)
- ASSETPURCHASE AGREEMENT (Filed With SEC on November 12, 2015)
- LICENSEAGREEMENT (Filed With SEC on August 12, 2015)
- STOCKPURCHASE AGREEMENT byand among IMPRIMISPHARMACEUTICALS, INC., JONATHANNGUYEN, JULIETRINH and JTPHARMACY, INC. (D/B/ACENTRAL ALLEN PHARMACY) Datedas of July 10, 2015 (Filed With SEC on August 12, 2015)
- [ImprimisLetterhead] (Filed With SEC on August 5, 2015)
- IMPRIMISPHARMACEUTICALS, INC. NONQUALIFIEDSTOCK OPTION AGREEMENT (Filed With SEC on August 5, 2015)
- FIRSTAMENDMENT TO AMENDEDAND RESTATED EMPLOYMENTAGREEMENT (Filed With SEC on August 5, 2015)
- IMPRIMISPHARMACEUTICALS, INC. EMPLOYMENTAGREEMENT (Filed With SEC on February 2, 2015)
- STOCKPURCHASE AGREEMENT byand among IMPRIMISPHARMACEUTICALS, INC., DENNISSAADEH, TINASULIC-SAADEH, SOUTHCOAST SPECIALTY COMPOUNDING (D/B/APARK COMPOUNDING) and... (Filed With SEC on December 2, 2014)
- LICENSEAGREEMENT (Filed With SEC on October 29, 2014)
- CONFIDENTIALTREATMENT REQUESTED. OMITTED PORTIONS ARE MARKED WITH [***] AND HAVE BEEN FILED SEPARATELY WITH THE SEC. (Filed With SEC on March 28, 2014)
- AMENDMENT TO ASSET PURCHASEAGREEMENT (Filed With SEC on November 6, 2013)
- CONFIDENTIAL TREATMENT REQUESTED.OMITTED PORTIONS ARE MARKED WITH [***] AND HAVE BEEN FILED SEPARATELY WITH THE SEC. ASSETPURCHASE AGREEMENT (Filed With SEC on November 6, 2013)
- CONFIDENTIAL TREATMENT REQUESTED. OMITTED PORTIONS ARE MARKED WITH [***] AND HAVE BEEN FILED SEPARATELY WITH THE SEC. (Filed With SEC on August 14, 2013)
- Strategic Alliance Agreement, dated February 18, 2013, by and between the Company and Professional Compounding Centers of America, Inc (Filed With SEC on February 21, 2013)
